
Please try another search
Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally. It operates through Pharmaceutical Business and Fitness Business segments. The company offers prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health activities. It also offers corporate advisory services; and researches and develops medical products. The company was formerly known as Tongfang Kontafarma Holdings Limited and changed its name to Kontafarma China Holdings Limited in September 2022. The company was incorporated in 2011 and is headquartered in Wan Chai, Hong Kong. Kontafarma China Holdings Limited is a subsidiary of China Health Management Investment Limited.
Name | Age | Since | Title |
---|---|---|---|
Feifei Wang | - | 2024 | Executive Chairman & President |
Yu Huang | 55 | 2014 | Non-Executive Director |
Zixiu Guo | - | 2024 | Financial Controller & Executive Director |
Lai Wah Tang | 68 | 2024 | Independent Non-Executive Director |
Ho Ming Ho | 53 | 2024 | Independent Non-Executive Director |
Xiaomin Yao | 62 | 2024 | Independent Non-Executive Director |
Linna Qiao | - | 2024 | VP & Executive Director |
Jiankun Liu | - | 2024 | Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review